Health tech investors say the founders who win them over aren’t the ones with all the answers, but the ones who know exactly what they don’t know — and build a team to cover the gap. The post What Health Tech Investors Love in Founders — and What They Can’t Stand appeared first on MedCity…
Priority Health partnered with Color Health and Grail to offer self-funded employers virtual cancer navigation, support and multi-cancer early detection beginning in 2027. The post Priority Health Launches 2 Cancer Support Solutions with Color Health, Grail appeared first on MedCity News.
Jessica Lamb says rewiring a domain with AI is the kind of large-scale change you only do if you have real CEO backing
State Medicaid programs must inform people affected by new work requirements with federally required notices, and most states are planning other types of outreach, including phone calls, public ads, and social media posts. This brief describes the federal outreach requirements and state plans, as well as the complexities and tight implementation timelines states face.
We’re about to enter a world beyond just talking to a chat tool about your health. AI tools are on the precipice of being able to take action on their advice. The post AI Will Reshape the Patient Experience appeared first on MedCity News.
The question is no longer whether healthcare innovation is accelerating. The question is where investors gain access to generate the strongest returns. The post Healthcare’s Next Source of Alpha Is Moving Upstream appeared first on MedCity News.
This isn’t just a bad year for measles. It looks to be the start of a bad era. Confirmed measles cases just hit a 35-year high, and it’s only July. Together with last year, the number of cases has exceeded the combined total over the previous 25 years. The vast majority of cases stem from…
Shirley Jennett, a retired nurse, loves her spacious ranch-style house in Denver, with its big backyard and gazebo. “I want to stay here,” she vowed. “And die here.” She might pull that off. In relatively good health, Jennett still drives to lunch with friends, does her own housekeeping and grocery shopping, and plows through a…
President Donald Trump’s proposed tariffs on imported generic drugs could raise some prices for patients, a key GOP lawmaker on health issues said this week. But he said that’s a potentially worthwhile trade-off to protect the nation’s drug supply. “The national security might be something worth paying for,” Sen. Bill Cassidy of Louisiana, chairman of…
Scribe Therapeutics’ IPO will support a pipeline led by a genetic medicine that represses expression of its target gene without making permanent changes. Common chronic cardiometabolic conditions are Scribe’s initial focus as the biotech works to bring genetic medicines beyond rare diseases. The post CRISPR Biotech Scribe Therapeutics Writes a New Chapter With $129M IPO…